Aromasin may prevent breast cancer recurrence

Aromasin pastilles
Photo Karl Stephan

Aromasin (exemestane) may prevent new cases of breast cancer, as well as recurrence in post-menopausal women also will be glad to know that exemestane may be available in generic form, soon in expired patent April 1 that would contribute to lower the cost of the drug, which reduces the number of newly diagnosed breast cancers.

This message is the result of research carried out by the NCIC clinical trials group of Queen's University in Ontario, Canada. results of the studies were presented this year by the American Society of Clinical Oncology meeting in Chicago. New England Journal of Medicine published study, which ran for 5 years and included more than 4,500 women living in North America, Spain, and France women in these studies were already menopausal and are identified as at high risk of breast cancer.

This is not the first time that hormone therapy was considered as chemoprevention for breast cancer. have been determined conventionally Tamoxifen for many pre-and post-menopausal women after treatment of breast estrogen sensitive cancer. prevents return of breast cancer by blocking estrogen receptors, but it does not stop the estrogen production., and the reason why Tamoxifen minus that many patients do not take it for a full five years, that is the standard regimethe side effects of Tamoxifen causes hot flashes, menopause like night sweats and raises the risk for cancer of the uterus, cataract and stem stroke.

Aromasin is milder side effects than Tamoxifen and acts differently. Aromasin and Tamoxifen blocks estrogen prevents estrogen production. Aromasin is aromatazy, which is often given to patients with cancer of the breast post menopausal, who have completed treatment for cancer of breast estrogen sensitive or. drugs would benefit for patients who have estrogen receptor negative breast cancer, such as Triple negative breast cancer (TNBC).

Do not rush out and ask your doctor to prescribe as a breast cancer prevention exemestane simply yet more research will need to be made on its benefits and risks, as well as its effectiveness in preventing the development of breast tumors in women at risk. But if the research holds up, this drug may prevent many mastectomies alongside earlier in young and old women, who have already had genetic testing and found to have a family, as well as a predisposition for breast cancer for women., which do not mind early case hot flashes in order to avoid breast tumor, side effects with exemestane does not seem too bad.

View the original article here